This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (25)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas R. Beam, Jr, MD; E. Diane Crigler, RN, MS; Jack K. Goldman, MD; Gerald Schiffman, PhD

JAMA. 1980;244(23):2621-2624.

Abstract
Ten control volunteers and 40 insulin-dependent diabetics were immunized with polyvalent pneumococcal vaccine (Pneumovax). The populations were similar except that diabetics were significantly older. In a double-blind fashion, diabetics were divided into two groups of 20; one received vaccine at baseline and saline placebo four weeks later. The second received saline, then vaccine. Antibody response was measured by radioimmunoassay. In general, insulin-dependent diabetics responded as quickly and equally as controls. Antibody titers did not decline at eight weeks. Incidence and intensity of adverse reactions were similar among diabetics and controls. There was no correlation between antibody response and age (r=-.078), mean glucose concentration (r=-.096), or duration of diabetes (r=-.064). We conclude that insulin-dependent diabetics respond as well as controls to immunization with pneumococcal polysaccharide vaccine.

(JAMA 1980;244:2621-2624)

Author Affiliations
From the Buffalo Veterans Administration Medical Center (Drs Beam and Goldman and Ms Crigler); the Department of Medicine (Drs Beam and Goldman) and the School of Nursing (Ms Crigler), State University of New York at Buffalo; and the Department of Microbiology and Immunology, State University of New York, Downstate Medical Center, Brooklyn (Dr Schiffman).

Footnotes
Reprint requests to 3495 Bailey Ave, Buffalo, NY 14215 (Dr Beam).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevention of Respiratory Infections in Adults: Influenza and Pneumococcal Vaccines
Fiebach and Beckett
Arch Intern Med 1994;154:2545-2557.
ABSTRACT  

Pneumococcal Vaccine Efficacy in Selected Populations in the United States
BOLAN et al.
ANN INTERN MED 1986;104:1-6.
ABSTRACT  

Previous Hospital Care and Pneumococcal Bacteremia: Importance for Pneumococcal Immunization
Fedson and Chiarello
Arch Intern Med 1983;143:885-889.
ABSTRACT  

Pneumococcal Vaccine: Clinical Efficacy and Effectiveness
SCHWARTZ
ANN INTERN MED 1982;96:208-220.
ABSTRACT